Sandra C. Cardoso-Silva
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 18, 2021
Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
Journal: Rheumatology (Oxford, England)
Published: January 04, 2021
Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis.
Journal: Journal of clinical medicine
Published: December 09, 2020
Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis.
Journal: Journal of autoimmunity
Published: September 08, 2020
CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro.
Journal: Frontiers in immunology
Published: April 24, 2020
CXCL4 suppresses tolerogenic immune signature of monocyte-derived dendritic cells.
Journal: European journal of immunology
Published: August 08, 2019
CXCL4 is a driver of cytokine mRNA stability in monocyte-derived dendritic cells.
Journal: Molecular immunology
Published: May 25, 2019
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
Journal: European journal of immunology
Published: January 30, 2019
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
Journal: Annals of the rheumatic diseases
Published: August 16, 2018
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
Journal: Journal of autoimmunity
Published: October 09, 2017
CXCL4 is a novel inducer of human Th17 cells and correlates with IL-17 and IL-22 in psoriatic arthritis.
Journal: European journal of immunology
Published: June 23, 2017
Last Updated: 09/26/2026